Search - tctmd.com

Displaying 1 - 20 of 58

Sort: Relevancy | Date

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Complex Coronary Cases 2023

In-Stent Restenosis: Update and Devices

Presenter: Melissa Chang

June 16, 2023

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

January 15, 2019

Presentation SCAI 2018

How to treat: Recurrent In-stent Restenosis

Presenter: Kenneth Chin

March 23, 2018

Presentation CHIP Florida 2018

In-stent Restenosis Due to Underexpanded Stent

Presenter: Nirat Beohar

January 22, 2018

Presentation CHIP Florida 2018

Recalcitrant In-stent Restenosis

Presenter: Jeffrey W. Moses

January 19, 2018

Presentation

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

July 19, 2017

Presentation TCT 2016

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Presenter: Gary S. Mintz, Robert-Jan van Geuns, Fernando Alfonso

November 02, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation JIM 2016

Session III - BRS Cases for High-risk Patients and Challenging Anatomy In-stent restenosis

Presenter: Manel Sabaté

February 09, 2016

Presentation ISET 2016

Treatment Strategies for Carotid In-Stent Restenosis

Presenter: D. Chris Metzger

February 07, 2016

Presentation

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

Presenter: Fernando Alfonso

June 30, 2015

Presentation ARCH 2015

How to Approach In-Stent Restenosis

Presenter: Craig M. Walker

April 10, 2015

Presentation

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Presenter: MA Magalhaes

December 11, 2014

Presentation TCT 2014

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Freek Nijhoff

September 16, 2014

Presentation TCT 2014

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Presenter: Bruno Scheller

September 16, 2014

Presentation TCT 2014

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

Presenter: James Min

September 16, 2014

Presentation TCT 2014

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

Presenter: John A. Bittl, Tullio Palmerini, Joo Myung Lee, MD

September 15, 2014

Presentation TCT 2014

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Presenter: Gregg W. Stone, Pieter C. Smits, Fernando Alfonso

September 14, 2014

Advertisement

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

In-Stent Restenosis: Update and Devices

Drug-Coated Therapy for ISR: Review of Options and Data

Frequency of TVR With DCB vs Second-Generation DES for Coronary In-Stent Restenosis

How to treat: Recurrent In-stent Restenosis

In-stent Restenosis Due to Underexpanded Stent

Recalcitrant In-stent Restenosis

Incidence, Procedural Management, and Clinical Outcomes of Coronary In-stent Restenosis

RIBS VI: A Prospective, Multicenter Registry of Bioresorbable Vascular Scaffolds in Patients With Coronary Artery Bare Metal or Drug-Eluting In-Stent Restenosis Six Month-Nine Month Clinical and Angiographic Follow-up Results

Role of OCT in Evaluation and treatment of In Stent Restenosis

Session III - BRS Cases for High-risk Patients and Challenging Anatomy In-stent restenosis

Treatment Strategies for Carotid In-Stent Restenosis

RIBS IV: Drug-Coated Balloon (DCB) vs Everolimus-Eluting Stent (EES) in Patients With In-Stent Restenosis of DES

How to Approach In-Stent Restenosis

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Antirestenotic Efficacy in the Treatment of In-Stent Restenosis: A Comparison of Two Paclitaxel Drug-Eluting Balloons With Different Coatings

A Novel Drug-Coated Scoring Balloon for the Treatment of Coronary In-Stent Restenosis: One Year Results of the PATENT-C First-in-Human Trial

Cost Comparisons of Invasive and Non-Invasive Diagnostic Evaluations for Patients with Suspected In-Stent Restenosis Following Implant of Metallic Stents and Bioresorbable___

TCT 270: Comparison Among a Drug-Eluting Balloon, Drug-Eluting Stent, and Plain Balloon Angioplasty for Treatment of In-Stent Restenosis: A Network Meta-analysis of 11 Randomized Controlled Trials

RIBS IV: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with Coronary In-Stent Restenosis of Drug-Eluting Stents

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content